-
EU authorities take further action in ongoing review of sartans
EU authorities take further action in ongoing review of sartans
-
EU authorities take further action in ongoing review of sartans
EU authorities take further action in ongoing review of sartans
Zheijiang Huahai placed under increased supervision by EU authorities and Aurobindo Pharma stopped from supplying irbesartan to the EU.
-
Sales of antibiotics for use in animals drop across the EU
Sales of antibiotics for use in animals drop across the EU
-
Sales of antibiotics for use in animals drop across the EU
Sales of antibiotics for use in animals drop across the EU
EMA’s new report shows that the overall sales of veterinary antimicrobials across Europe decreased by more than 20% between 2011 and 2016.
-
Update on Brexit preparations
Update on Brexit preparations
-
Update on Brexit preparations
Update on Brexit preparations
EMA’s Brexit preparedness business continuity plan entered into its third phase on 1 October 2018. A detailed implementation plan is now available.
-
Boosting the development of medicines for children
Boosting the development of medicines for children
-
Boosting the development of medicines for children
Boosting the development of medicines for children
EMA and the European Commission have published a new action plan to support the development of medicines for children in Europe, addressing challenges and findings identified by stakeholders.
